Cargando…
Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling
The development of extended-release dosage forms with adequate drug release is a challenge for pharmaceutical companies, mainly when the drug presents high solubility, as in Biopharmaceutics Classification System (BCS) class I. This study aimed to develop extended-release mini-tablets containing met...
Autores principales: | Issa, Michele Georges, de Souza, Natalia Vieira, Jou, Bruna Wenyi Chuang, Duque, Marcelo Dutra, Ferraz, Humberto Gomes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146084/ https://www.ncbi.nlm.nih.gov/pubmed/35631478 http://dx.doi.org/10.3390/pharmaceutics14050892 |
Ejemplares similares
-
Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
por: Carapeto, Gustavo Vaiano, et al.
Publicado: (2023) -
Development of a Discriminative Dissolution Method, Using In-Silico Tool for Hydrochlorothiazide and Valsartan Tablets
por: Leon, Rosmery Merma, et al.
Publicado: (2023) -
Metoprolol succinate extended release/hydrochlorothiazide combination tablets
por: Hainer, James W, et al.
Publicado: (2007) -
Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations
por: Khan, Dilawar, et al.
Publicado: (2021) -
Design and characterization of controlled release tablet of metoprolol
por: Singhvi, Gautam, et al.
Publicado: (2012)